128 related articles for article (PubMed ID: 33125811)
21. Learning Non-rigid Deformations for Robust, Constrained Point-based Registration in Image-Guided MR-TRUS Prostate Intervention.
Onofrey JA; Staib LH; Sarkar S; Venkataraman R; Nawaf CB; Sprenkle PC; Papademetris X
Med Image Anal; 2017 Jul; 39():29-43. PubMed ID: 28431275
[TBL] [Abstract][Full Text] [Related]
22. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
23. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
24. Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images.
Orlando N; Gillies DJ; Gyacskov I; Romagnoli C; D'Souza D; Fenster A
Med Phys; 2020 Jun; 47(6):2413-2426. PubMed ID: 32166768
[TBL] [Abstract][Full Text] [Related]
25. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
[TBL] [Abstract][Full Text] [Related]
26. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
[TBL] [Abstract][Full Text] [Related]
27. Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study.
Imani F; Zhuang B; Tahmasebi A; Kwak JT; Xu S; Agarwal H; Bharat S; Uniyal N; Turkbey IB; Choyke P; Pinto P; Wood B; Moradi M; Mousavi P; Abolmaesumi P
Int J Comput Assist Radiol Surg; 2015 Jun; 10(6):727-35. PubMed ID: 25843948
[TBL] [Abstract][Full Text] [Related]
28. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience.
Mouraviev V; Verma S; Kalyanaraman B; Zhai QJ; Gaitonde K; Pugnale M; Donovan JF
J Endourol; 2013 Jul; 27(7):820-5. PubMed ID: 22966987
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
30. Rotational-slice-Based prostate segmentation using level set with shape constraint for 3D end-firing TRUS guided biopsy.
Qiu W; Yuan J; Ukwatta E; Tessier D; Fenster A
Med Image Comput Comput Assist Interv; 2012; 15(Pt 1):537-44. PubMed ID: 23285593
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Woo S; Suh CH; Eastham JA; Zelefsky MJ; Morris MJ; Abida W; Scher HI; Sidlow R; Becker AS; Wibmer AG; Hricak H; Vargas HA
Eur Urol Oncol; 2019 Nov; 2(6):605-616. PubMed ID: 31204311
[TBL] [Abstract][Full Text] [Related]
32. Real-time registration of 3D to 2D ultrasound images for image-guided prostate biopsy.
Gillies DJ; Gardi L; De Silva T; Zhao SR; Fenster A
Med Phys; 2017 Sep; 44(9):4708-4723. PubMed ID: 28666058
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Real-Time Virtual Sonography Navigation Versus BioJet Navigation on Magnetic Resonance Imaging-Guided Prostate Needle Biopsy: A Single Institutional Analysis.
Nagai T; Naiki T; Hamamoto S; Etani T; Naiki-Ito A; Nakagawa M; Iida K; Iwatsuki S; Taguchi K; Maruyama T; Kawai N; Takahashi S; Yasui T
J Endourol; 2020 Jul; 34(7):739-745. PubMed ID: 32316763
[No Abstract] [Full Text] [Related]
34. Multimodal image-guided prostate fusion biopsy based on automatic deformable registration.
Zettinig O; Shah A; Hennersperger C; Eiber M; Kroll C; Kübler H; Maurer T; Milletarì F; Rackerseder J; Schulte Zu Berge C; Storz E; Frisch B; Navab N
Int J Comput Assist Radiol Surg; 2015 Dec; 10(12):1997-2007. PubMed ID: 26054983
[TBL] [Abstract][Full Text] [Related]
35. Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy.
Ukimura O; Hirahara N; Fujihara A; Yamada T; Iwata T; Kamoi K; Okihara K; Ito H; Nishimura T; Miki T
Int J Urol; 2010 Oct; 17(10):890-3. PubMed ID: 20812938
[TBL] [Abstract][Full Text] [Related]
36. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
37. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
38. Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience.
Vilanova JC; Pérez de Tudela A; Puig J; Hoogenboom M; Barceló J; Planas M; Sala S; Thió-Henestrosa S
Abdom Radiol (NY); 2020 Dec; 45(12):4150-4159. PubMed ID: 32705314
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
